These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21896210)

  • 1. A cell factory of Bacillus subtilis engineered for the simple bioconversion of myo-inositol to scyllo-inositol, a potential therapeutic agent for Alzheimer's disease.
    Yamaoka M; Osawa S; Morinaga T; Takenaka S; Yoshida K
    Microb Cell Fact; 2011 Sep; 10():69. PubMed ID: 21896210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new-generation of Bacillus subtilis cell factory for further elevated scyllo-inositol production.
    Tanaka K; Natsume A; Ishikawa S; Takenaka S; Yoshida KI
    Microb Cell Fact; 2017 Apr; 16(1):67. PubMed ID: 28431560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved Bacillus subtilis cell factory for producing scyllo-inositol, a promising therapeutic agent for Alzheimer's disease.
    Tanaka K; Tajima S; Takenaka S; Yoshida K
    Microb Cell Fact; 2013 Dec; 12():124. PubMed ID: 24325193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bacterial cell factory converting glucose into scyllo-inositol, a therapeutic agent for Alzheimer's disease.
    Michon C; Kang CM; Karpenko S; Tanaka K; Ishikawa S; Yoshida KI
    Commun Biol; 2020 Mar; 3(1):93. PubMed ID: 32123276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A second-generation Bacillus cell factory for rare inositol production.
    Tanaka K; Takanaka S; Yoshida K
    Bioengineered; 2014; 5(5):331-4. PubMed ID: 25482235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic engineering of Corynebacterium glutamicum for production of scyllo-inositol, a drug candidate against Alzheimer's disease.
    Ramp P; Lehnert A; Matamouros S; Wirtz A; Baumgart M; Bott M
    Metab Eng; 2021 Sep; 67():173-185. PubMed ID: 34224896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of scyllo-Inositol: Conversion of Rice Bran into a Promising Disease-Modifying Therapeutic Agent for Alzheimer's Disease.
    Yoshida KI; Ishikawa S
    J Nutr Sci Vitaminol (Tokyo); 2019; 65(Supplement):S139-S142. PubMed ID: 31619615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacillus subtilis iolU encodes an additional NADP
    Kang DM; Tanaka K; Takenaka S; Ishikawa S; Yoshida KI
    Biosci Biotechnol Biochem; 2017 May; 81(5):1026-1032. PubMed ID: 28043209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthesis and production of quercitols and their application in the production of pharmaceuticals: current status and prospects.
    Itoh N
    Appl Microbiol Biotechnol; 2018 Jun; 102(11):4641-4651. PubMed ID: 29663050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of scyllo-inositol as a therapeutic treatment of AD-like pathology.
    Fenili D; Brown M; Rappaport R; McLaurin J
    J Mol Med (Berl); 2007 Jun; 85(6):603-11. PubMed ID: 17279347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of a novel (-)-vibo-quercitol 1-dehydrogenase from Burkholderia terrae suitable for production of (-)-vibo-quercitol from 2-deoxy-scyllo-inosose.
    Itoh N; Kurokawa J; Toda H; Konishi K
    Appl Microbiol Biotechnol; 2017 Oct; 101(20):7545-7555. PubMed ID: 28905086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus subtilis IolQ (DegA) is a transcriptional repressor of iolX encoding NAD
    Kang DM; Michon C; Morinaga T; Tanaka K; Takenaka S; Ishikawa S; Yoshida KI
    BMC Microbiol; 2017 Jul; 17(1):154. PubMed ID: 28693424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of two scyllo-inositol dehydrogenases in Bacillus subtilis.
    Morinaga T; Ashida H; Yoshida KI
    Microbiology (Reading); 2010 May; 156(Pt 5):1538-1546. PubMed ID: 20133360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient pathway-driven
    Kurashiki R; Takahashi M; Okumura Y; Ono T; Endo H; Makino K; Fukui K; Yokoyama K; Ishikawa S; Yoshida K-i; Ohshiro T; Suzuki H
    Appl Environ Microbiol; 2024 Jul; ():e0028124. PubMed ID: 38975762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial synthesis of health-promoting inositols.
    Yoshida KI; Bott M
    Curr Opin Biotechnol; 2024 Jun; 87():103114. PubMed ID: 38520822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive glucose dehydrogenase elevates intracellular NADPH levels and luciferase luminescence in Bacillus subtilis.
    Wu Y; Kawabata H; Kita K; Ishikawa S; Tanaka K; Yoshida KI
    Microb Cell Fact; 2022 Dec; 21(1):266. PubMed ID: 36539761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permeabilized Escherichia coli Whole Cells Containing Co-Expressed Two Thermophilic Enzymes Facilitate the Synthesis of scyllo-Inositol from myo-Inositol.
    Li Y; Liu S; You C
    Biotechnol J; 2020 Feb; 15(2):e1900191. PubMed ID: 31487423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding mechanism of inositol stereoisomers to monomers and aggregates of Aβ(16-22).
    Li G; Pomès R
    J Phys Chem B; 2013 Jun; 117(22):6603-13. PubMed ID: 23627280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological, Biochemical, and Structural Bioinformatic Analysis of the Multiple Inositol Dehydrogenases from Corynebacterium glutamicum.
    Ramp P; Pfleger C; Dittrich J; Mack C; Gohlke H; Bott M
    Microbiol Spectr; 2022 Oct; 10(5):e0195022. PubMed ID: 36094194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scyllo-inositol depletion in hepatic encephalopathy.
    Lien YH; Michaelis T; Moats RA; Ross BD
    Life Sci; 1994; 54(20):1507-12. PubMed ID: 8190025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.